Comparing Methods for Accounting for Seasonal Variability in a Biomarker When Only a Single Sample Is Available: Insights From Simulations Based on Serum 25-Hydroxyvitamin D
Authors:
- Yiting WangYWYiting Wang
- Eric J. JacobsEJEric J. Jacobs
- Marjorie L. McCulloughMMMarjorie L. McCullough
- Carmen RodriguezCRCarmen Rodriguez
- Michael J. ThunMTMichael J. Thun
- Eugenia E. CalleECEugenia E. Calle
- W. Dana FlandersWFW. Dana Flanders
Open Access
- 30 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 170 (1) , 88-94
Abstract
In biomarker-disease association studies, the long-term average level of a biomarker is often considered the optimal measure of exposure. Long-term average levels may not be accurately measured from a single sample, however, because of systematic temporal variation. For example, serum 25-hydroxyvitamin D (25(OH)D) concentrations may fluctuate because of seasonal variation in sun exposure. Association studies of 25(OH)D and cancer risk have used different strategies to minimize bias from such seasonal variation, including adjusting for date of sample collection (DOSC), often after matching on DOSC, and/or using season-specific cutpoints to assign subjects to exposure categories. To evaluate and understand the impact of such strategies on potential bias, the authors simulated a population in which 25(OH)D levels varied between individuals and by season, and disease risk was determined by long-term average 25(OH)D. Ignoring temporal variation resulted in bias toward the null. When cutpoints that did not account for DOSC were used, adjustment for DOSC sometimes resulted in bias away from the null. Using season- or month-specific cutpoints reduced bias toward the null and did not cause bias away from the null. To avoid potential bias away from the null, using season- or month-specific cutpoints may be preferable to adjusting for DOSC.Keywords
This publication has 18 references indexed in Scilit:
- Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCancer Epidemiology, Biomarkers & Prevention, 2008
- A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate CancerPLOS Medicine, 2007
- The 25-hydroxyvitamin D threshold for better healthThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006
- A Prospective Nested Case-Control Study of Vitamin D Status and Pancreatic Cancer Risk in Male SmokersCancer Research, 2006
- Who, what, where and when—influences on cutaneous vitamin D synthesisProgress in Biophysics and Molecular Biology, 2006
- Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Circannual Rhythms and Interactions of Vitamin D Metabolites, Parathyroid Hormone, and Biochemical Markers of Skeletal Homeostasis: A Prospective StudyJournal of Bone and Mineral Research, 2000
- When Measurement Errors Correlate with TruthEpidemiology, 1995
- Seasonal Changes in Human Plasma Levels of 25-Hydroxyvitamin DNature, 1974